Sony has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Nucleus surgical imaging platform for operating rooms and laboratories.
Nucleus is designed to support display resolution of up to 4K using existing network infrastructure and provide enhanced workflow for operating rooms and clinical spaces with direct access to imaging data from a central dashboard. Secure, managed access allows healthcare professionals to access and manage video and audio content in near real-time for collaboration and teaching purposes.
Smart applications and additional optional features can be added remotely as they are released. The platform also supports third-party applications via application programming interfaces (APIs) and a variety of mechanisms and tools.
The company plans to begin marketing Nucleus in the U.S. immediately. There currently are more than 500 operating room installations of Nucleus in the U.K., Belgium, Sweden, and other locations, according to the company.
